celecoxib has been researched along with Arterial Occlusive Diseases in 1 studies
Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Celecoxib is a potential inhibitor of neointimal formation by blocking injury-induced Akt activation." | 5.32 | Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling. ( Jeon, SI; Kim, HS; Kim, SH; Lee, MM; Oh, BH; Park, KW; Park, YB; Walsh, K; Yang, HM; You, HJ; Youn, SW, 2004) |
| "Celecoxib is a potential inhibitor of neointimal formation by blocking injury-induced Akt activation." | 1.32 | Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling. ( Jeon, SI; Kim, HS; Kim, SH; Lee, MM; Oh, BH; Park, KW; Park, YB; Walsh, K; Yang, HM; You, HJ; Youn, SW, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, HM | 1 |
| Kim, HS | 1 |
| Park, KW | 1 |
| You, HJ | 1 |
| Jeon, SI | 1 |
| Youn, SW | 1 |
| Kim, SH | 1 |
| Oh, BH | 1 |
| Lee, MM | 1 |
| Park, YB | 1 |
| Walsh, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00500279] | Phase 4 | 900 participants (Anticipated) | Interventional | 2006-11-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for celecoxib and Arterial Occlusive Diseases
| Article | Year |
|---|---|
Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling.
Topics: Animals; Apoptosis; Arterial Occlusive Diseases; Celecoxib; Cell Proliferation; Cell Survival; Cyclo | 2004 |